Success Metrics

Clinical Success Rate
84.9%

Based on 186 completed trials

Completion Rate
85%(186/219)
Active Trials
27(9%)
Results Posted
47%(87 trials)
Terminated
33(10%)

Phase Distribution

Ph not_applicable
55
17%
Ph phase_4
77
24%
Ph phase_2
62
20%
Ph early_phase_1
4
1%
Ph phase_1
29
9%
Ph phase_3
75
24%

Phase Distribution

33

Early Stage

62

Mid Stage

152

Late Stage

Phase Distribution302 total trials
Early Phase 1First-in-human
4(1.3%)
Phase 1Safety & dosage
29(9.6%)
Phase 2Efficacy & side effects
62(20.5%)
Phase 3Large-scale testing
75(24.8%)
Phase 4Post-market surveillance
77(25.5%)
N/ANon-phased studies
55(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.5%

186 of 237 finished

Non-Completion Rate

21.5%

51 ended early

Currently Active

27

trials recruiting

Total Trials

316

all time

Status Distribution
Active(34)
Completed(186)
Terminated(51)
Other(45)

Detailed Status

Completed186
unknown41
Terminated33
Withdrawn18
Recruiting17
Active, not recruiting10

Development Timeline

Analytics

Development Status

Total Trials
316
Active
27
Success Rate
84.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (1.3%)
Phase 129 (9.6%)
Phase 262 (20.5%)
Phase 375 (24.8%)
Phase 477 (25.5%)
N/A55 (18.2%)

Trials by Status

completed18659%
not_yet_recruiting72%
suspended41%
terminated3310%
withdrawn186%
recruiting175%
unknown4113%
active_not_recruiting103%

Recent Activity

Clinical Trials (316)

Showing 20 of 316 trialsScroll for more
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT07713186Phase 4

Azithromycin in Atopic Dermatitis

Not Yet Recruiting
NCT04287049Phase 2

A Study of Standard Drugs for Mycobacterium Avium Complex

Completed
NCT04069312Phase 3

Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial

Completed
NCT07164131Phase 4

Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

Recruiting
NCT06082037Phase 3

A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction

Recruiting
NCT04669288Phase 3

AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department

Terminated
NCT05922761Phase 2

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Recruiting
NCT06273891Phase 3

Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes

Active Not Recruiting
NCT06618534Phase 2

Azithromycin for Meningococcal Carriage

Completed
NCT02754583Phase 3

Sanitation, Water, and Instruction in Face-washing for Trachoma I/II

Completed
NCT07615842Phase 1

Assessing the Impact of Unnecessary Antibiotic Treatment on the Development of Appropriate Adaptive Immune Responses in Malnourished Bangladeshi Infants

Not Yet Recruiting
NCT03532464Phase 4

Azithromycin Compared With Doxycycline for Treating Anorectal Chlamydia Trachomatis Infection Concomitant to a Vaginal Infection

Completed
NCT02707042Phase 1

Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)

Completed
NCT07608328Phase 4

Azithromycin to Modify Bronchiectasis Exacerbation Risk

Not Yet Recruiting
NCT05961189Early Phase 1

Influence of Short-Term Antibiotic Therapy on Exercise

Completed
NCT05842681Not Applicable

Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Recruiting
NCT04310930Phase 2

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment

Recruiting
NCT07314281Phase 4

Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever

Recruiting
NCT05119166

International Milk Composition (IMiC) Consortium

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
316